Disubstituted ureas and uses thereof in treating heart failure
US8101617B2 · kind B2 · utility
25Cited by
36References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2008 |
| Grant date | Jan 24, 2012 |
| Priority date | — |
| Expiry date | Nov 8, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.